Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft

Transplant Immunology

Volumn 13, Issue 2, 2004, Pages 139-146

  Donckier, Vincent ^a   Troisi, Roberto ^b   Toungouz, Michel ^a   Colle, Isabelle ^c   Vlierberghe, Hans Van ^c   Jacquy, Caroline ^c   Martiat, Philippe ^d   Stordeur, Patrick ^a   Zhou, Ling ^a   Boon, Nathalie ^a   Lambermont, Micheline ^a   Schandené, Liliane ^a   Van Laethem, Jean Luc ^a   Noens, Lucien ^c   Gelin, Michel ^a   De Hemptinne, Bernard ^b   Goldman, Michel ^a  

^a ERASME HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d JULES BORDET INSTITUTE   (Belgium)

Author keywords

Cancer; Conditioning; Liver; Non myeloablative; Stem cell; Tolerance; Transplantation

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHYLPREDNISOLONE; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CADAVER; CANCER RECURRENCE; CANCER RISK; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEASIBILITY STUDY; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOLOGY; HEMATOPOIETIC CELL; HISTOLOGY; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LAPAROTOMY; LIVER CANCER; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE; MALE; PRIORITY JOURNAL; SIDE EFFECT; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TOXICITY; TRANSPLANTATION TOLERANCE;

ANTILYMPHOCYTE SERUM; ANTINEOPLASTIC AGENTS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FATAL OUTCOME; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RNA, MESSENGER; SIROLIMUS; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 4544223677     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2004.05.004     Document Type: Article

References (25)

1. Bismuth H., Chiche L., Adam R., et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhosis. Ann. Surg. 218:1993;145-151
2. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 334:1996;693-699
3. Iwatsuki S., Todo S., Marsh J.W., et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or liver transplantation. J. Am. Coll. Surg. 187:1998;358-364
4. Mazariegos G.V., Reyes J., Marino I.R., et al. Weaning of immunosuppression in liver transplant recipients. Transplantation. 63:1997;243-249
5. Bühler L.H., Spitzer T.R., Sykes M., et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation. 74:1992;1405-1409
6. Sayegh M.H., Fine N.A., Smith J.L., et al. Immunological tolerance to renal allografts after bone marrow transplants from the same donors. Ann. Intern. Med. 114:1991;954-955
7. Helg C., Chapuis B., Bolle J., et al. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic BMT. Transplantation. 58:1994;1420-1422
8. Kadry Z., Mullhaupt B., Renner E.L., et al. Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinoma. Transplantation. 76:2003;1003-1006
9. Wekerke T., Sayegh M.H., Hill J., et al. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the 18 induction of mixed chimerism and tolerance. Transplantation. 63:1999;1348-1355
10. Wekerle T., Kurtz J., Ito H., et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat. Med. 6:2000;464-469
11. Ko D.S., Bartholomew A., Poncelet A.J., et al. Demonstration of multilineage chimerism in a nonhuman primate concordant xenograft model. Xenotransplantation. 5:1998;298-307
12. Sykes M. Mixed chimerism and transplant tolerance. Immunity. 14:2001;417-424
13. Gur H., Krauthgamer R., Berebi A., et al. Tolerance induction by megadose hematopoietic progenitor stem cells: Expansion of veto cells by short-term culture of purified human CD34(+) cells. Blood. 99:2002;4174-4181
14. Pinkel D., Straume T., Gray J.W. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. U. S. A. 83:1986;2934-2938
15. Stordeur P., Poulin L.F., Craciun L., et al. Cytokine mRNA quantification by real-time PCR. J. Immunol. Methods. 259:2002;55-64. (Erratum in: J Immunol Methods 2002; 262:229)
16. Stordeur P., Zhou L., Byl B., et al. Immune monitoring in whole blood using real-time PCR. J. Immunol. Methods. 276:2003;69-77
17. Spitzer T.R., Delmonico F., Tolkoff-Rubin N., et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation. 68:1999;480-484
18. Kimikawa M., Sachs D.H., Colvin R.B., et al. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation. 64:1997;709-716
19. Starzl T.E., Murase N., Abu-Elmagd K., et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 361:2003;1502-1510
20. Devlin J., Doherty D., Thomson L., et al. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology. 27:1998;926-933
21. Thomson A.W., Mazariegos G.V., Reyes J., et al. Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation. 72:2001;S13-S22
22. Cavazzana-Calvo M., Andre-Schmutz I., Hacein-Bey-Abina S., Bensoussan D., Le Deist F., Fischer A. Improving immune reconstitution while preventing graft-versus-host disease in allogeneic stem cell transplantation. Semin. Hematol. 39:2002;32-40
23. Bachar-Lustig E., Rachamim N., Li H.W., Lan F., Reisner Y. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat. Med. 1:1995;1268-1273
24. Fry T.J., Christensen B.L., Komschlies K.L., Gress R.E., Mackall C.L. Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood. 97:2001;1525-1533
25. Fry T.J., Mackall C.L. Interleukin-7: from bench to clinic. Blood. 99:2002;3892-3904